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In this issue of Immunity, Chaussabel et al. (2008) apply an inductive approach to pathway discovery identi-
fying modular units that govern human immune biology.‘‘It is impossible for the human in-
tellect to grasp ideas of absolute
continuity of motion. Laws of mo-
tion of any kind only become com-
prehensible to man when he can
examine arbitrarily selected units
of that motion. But, at the same
time, it is this arbitrary division of
continuous motion into discontinu-
ous units which gives rise to a large
proportion of human error.’’
—LeoTolstoy,WarandPeace, III: 3
It is increasingly appreciated that
monothematic, deductive reasoning ap-
plied to the testing of individual genes or
proteins does not efficiently embrace the
complexity of human immune biology
(Marincola, 2007; Benoist et al., 2006).
Deductive reasoning aims at confirma-
tion of hypotheses by minimizing experi-
mental variables. However, this reasoning
when applied to the clinics needs to con-
front the uncontrollable nature of human
biology molded by the heterogeneous ge-
netic background of patients, their pheno-
typic adaptations to environmental forces,
and, in some instances, the rapid evolu-
tion of disease dictated by unstable viral
or neoplastic genomes. Thus, nonlinear
mathematics may better fit the purposeof comprehending the host reaction to
a pathogenic insult in its globality (Dalgle-
ish, 1999). Indeed, biology manifests sev-
eral characteristics of chaotic systems in
which repetitions, given a sufficient num-
ber of permutations, progressively exfoli-
ate random associations leaving a bare
stem of recurrent patterns linked by
necessity to a particular phenomenon.
Identification of these recurrent themes
segregates relevant from irrelevant ob-
servations. Thus, as an alternative to de-
ductive reasoning, inductive reasoning
moves from observation to broader gen-
eralizations, allowing the formulation of
evidence-based hypotheses. This rea-
soning is the impetus of the work by
Chaussabel et al. (2008) in which they ap-
plied inductive reasoning to pathway dis-
covery and identified operational units
comprising sets of functionally related
genes that are differentially expressed
by peripheral blood mononuclear cells
(PBMCs) in distinct immune pathologies.
This discovery provides a framework for
an evidence-based approach to system
immunology.
Inductive reasoning applied to immu-
nology has to confront the daunting num-
ber of permutations arising from thousand
of genes interacting with one another.ImmuCurrent technology allows the accumula-
tion of genome-wide information about
coordinate expression patterns. How-
ever, the extraordinary volume of data
generated is not matched by the capacity
of the human brain that is ‘‘poorly equip-
ped to handle the multidimensionality
that results from these broad analyses’’
(Benoist et al., 2006). Thus, the promises
offered by the ‘‘omic’’ revolution pro-
duced fewer results than originally antici-
pated because, in part, of an unprepared
audience of biologists and clinicians
whose familiarity with bioinformatics prin-
ciples is not commensurate to the present
needs (Bialek and Botstein, 2004).
Deductive reasoning applied to biology
traditionally follows a ‘‘top-down’’ ap-
proach: A gene or protein is responsible
for a given phenotype through a direct
cause-effect relationship. However, be-
cause genes and their products interact
and modulate each other’s expression,
this linearity is rarely unambiguous and
clusters of genes need to be assembled
into molecular pathways to explain bio-
logical functions. In turn, integration of ex-
perimentally defined pathways constructs
virtual networks in which biological inter-
actions are predicted according to theo-
retical algorithms (Avila-Campillo et al.,nity 29, July 18, 2008 ª2008 Elsevier Inc. 9
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pret high-density data but because they
are predominantly derived from experi-
mental models, their clinical relevance
remains questionable.
In this issue of Immunity, Chaussabel
et al. (2008) apply ‘‘bottom-up’’ inductive
reasoning to the understanding of human
immune biology (Figure 1). Although the
bioinformatics jargon may appear intimi-
dating, the logic followed by the authors
was straightforward. On the basis of the
hypothesis that the transcription of PBMCs
may be disease specific, the authors ana-
lyzed 239 PBMC samples from individuals
with different immune conditions (juvenile
idiopathic arthritis, systemic lupus erythe-
matosus, acute infections, or liver-trans-
plant recipients undergoing immune-sup-
pressive therapy). In addition, two diseases
that previously to this work had not been
clearly associated with immune pathology
were included: metastatic melanoma and
type I diabetes. The authors observed that
distinct clinical entities consistently displayed
characteristic transcriptional patterns that
consisted of clusters of coordinately ex-10 Immunity 29, July 18, 2008 ª2008 Elseviepressed genes. Moreover, the investiga-
tors observed that genes belonging to
each cluster shared similar functions,
and therefore, each cluster represented
a broad transcriptional unit that could in
approximately half of the cases be subse-
quently assigned a functional interpreta-
tion: The authors called these transcrip-
tional units ‘‘modules.’’ We will refer to
them also as functional units when a broad
function could be assigned to them or
simply transcriptional units when no func-
tional interpretation could be given on the
basis of the current gene-annotation as-
signments. Good examples of functional
units are the plasma cell and B cell signa-
tures (M1.1 and M1.3, respectively) or
interferon-inducible genes (M3.1), which
have been shown to occur in various
clinical conditions associated with
chronic and/or acute inflammatory pro-
cesses (Wang et al., 2008). Moreover,
Chaussabel et al. (2008) observed that
the pattern of expression of individual
modules was disease specific and, at
least in the case of systemic lupus erythe-
matosus, correlated with disease activity.r Inc.Thus, as in the cosmos, billion of stars
form a galaxy (module), and each galaxy
participates in a cluster (physiologic sta-
tus), which, in turn, is part of a supercluster
(patient’s condition); our genome can be
potentially divided in functional modules,
and the more or less harmonious interac-
tions among them can be followed with
the relative simplicity with which astrono-
mers follow the movement of billion of
stars congregated into cosmic units.
This reduction of information from hun-
dred of genes into a few, functionally de-
fined modular units will facilitate the inter-
pretation of immunological phenomena
offering, at the same time, integrated bio-
markers for clinical correlations.
The authors tested the validity of their
discovery by predicting modular patterns
in independent patient samples; in addi-
tion, ‘‘transcriptional vectors’’ were calcu-
lated that simply represent the arithmetic
average of the expression values for sub-
sets of genes representing each individual
module. Plotting the transcriptional vector
for each module on a spider graph, one
could create individual patients’ expres-
sion profiles that were strikingly different
from those obtained from healthy volun-
teers and, in the case of systemic lupus
erythematosus, that were predictive of
disease activity and could be used to
monitor disease progression.
This ‘‘bottom-up’’ approach is evidence
based rather than based on theoretical
assumptions. Therefore, the modules
identified are likely to represent the down-
stream result of a clinically relevant deter-
minism. Observations from other groups
strongly support the validity of the ap-
proach: Critchley-Thorne et al. (2007) ob-
served distinct transcriptional patterns in
PBMCs from patients with metastatic
melanoma compared to normal individ-
uals; it would be interesting to reevaluate
their analysis in the context of the modular
network. He et al. (2006) observed that the
transcriptional pattern of PBMCs from pa-
tients with chronic hepatitis C virus infec-
tion stimulated with interferon-a could
predict treatment outcome after the sys-
temic administration of the same agent.
Thus, transcriptional patterns of PBMCs
could serve as an easy-to-access lookout
for a given disease status and could be
exploited to identify biomarkers useful
for diagnostic, prognostic, and therapeu-
tic purposes (i.e., patient stratification
during enrollment in clinical trials).Figure 1. The Pyramid of System Immunology
Most investigators have adopted a ‘‘top-down’’ approach to build networks that could explain cellular
functions in their globality; the function of a given gene is the premise from which its interactions with other
genes are deducted to formulate pathways that lead to coordinated cellular functions (a concept similar to
the experimental observation of ‘‘operons’’). Because the process proceeds in the downstream direction,
it becomes increasingly speculative. Here, the authors applied a ‘‘bottom-up’’ (inductive) approach and
identified operational (transcriptional) units that they called modules through the identification of genes
co-coordinately expressed in distinct pathophysiological conditions; this evidence-based reasoning of-
fers two advantages: It provides a road map for biomarker discovery, and it identifies transcriptional net-
works that may lead the basic scientist toward the identification of upstream events that lead to patho-
genic processes and that, therefore, are most probably relevant to human suffering.
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paper are limited for a variety of under-
standable reasons: The diseases studied
are few and limited to immune patholo-
gies. We have observed that a panel of
common cancer biomarkers could be
identified by comparing a variety of pri-
mary and metastatic cancers of different
histology to a broad array of normal tis-
sues (Basil et al., 2006). It is possible the
modular approach could discover bet-
ter-defined functional units relevant to
cancer and other diseases. As stated by
the authors, future efforts should be
aimed at broadening the database to
other pathologies. The study addresses
potential clinical implications of the mod-
ular approach by demonstrating a semi-
quantitative relationship between tran-
scriptional vectors and disease activity in
the context of systemic lupus erythema-
tosus. However, the predictive accuracy
of the modular pattern at clinically rele-
vant stages of disease and its relationship
to treatment outcome in the context of
lupus or other diseases will need to be
tested for early diagnostic, prognostic,
and predictive purposes. Furthermore,
biomarkers are needed as surrogate end-
points; it will be important to test whether
individual patient’s modular activity could
serve as a useful monitor of response to
therapy, early recurrence, and long-term
survival compared to currently followed
gene-specific biomarkers. A caveat of
the present study is intrinsic to its design;
by looking for recurrent themes withina particular disease, it is possible that
subtle differences that are within each
disease category and that may bear clini-
cal significance in diagnostic, prognostic,
or predictive terms may have been
missed; although the predictive value of
vector analysis in systemic lupus erythe-
matosus suggest good quantitative corre-
lation between transcriptional information
and disease activity, it is possible that
qualitative difference were excluded by
eliminating less consistent expression
patterns. This limitation could be over-
come in future studies by subcategorizing
individual diseases according to clinically
relevant parameters.
In summary, Chaussabel et al. (2008)
suggest an inductive approach to path-
way discovery: Disease-specific gene-
expression patterns are identified and
condensed into few functional units;
these are presumed to represent down-
stream effects of biological mechanisms
determining the disease status. Some of
them are representative of cell types,
whereas others represent cellular func-
tions such as immune-activation path-
ways, cell-cycle and metabolic functions,
etc.; these observations have important
scientific implications because an up-
stream look at the pathways controlling
the activation of each functional unit may
provide insight about disease pathogene-
sis. This evidence-based analysis repre-
sents a paradigm shift in which system
biology (immunology) is approached
from the bedside, yielding informationImmunimost likely to be relevant to human suffer-
ing and confronting the basic immunolo-
gist and cell biologist with the challenge
of aligning experimental observations
with the reality of human disease ap-
proached in its uncontrollable complexity.
Moreover, the modular approach offers
practical applications as a global-bio-
marker-discovery tool that will need to
be aggressively validated in the future.
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